噻托溴铵和普米克令舒治疗老年慢性阻塞性肺疾病临床分析  

The Clinical Analyze of Curing Older Chronic Obstructive Pulmonary Disease by Tiotropium Bromide and Budesonide

作　　者：张玮[1] 刘锋涛[1] 王伟娜[1] 

机构地区：[1]山西太原武警山西总队医院呼吸科,太原030006

出　　处：《中国医药导刊》2013年第3期468-468,470,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:探讨噻托溴铵和普米克令舒治疗老年慢性阻塞性肺疾病(COPD)临床疗效情况。方法:分析我院收治的COPD患者临床资料,对照组(单独应用普米克令舒治疗组)40例和观察组(噻托溴铵联合普米克令舒治疗组)40例。结果:观察组肺功能和生活质量均明显优于对照组,P<0.05,差异均有统计学意义。结论:噻托溴铵和普米克令舒联合治疗COPD临床症状改善明显。Objective： To approach clinical curative effect of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide.Method：To analyze clinical data of of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide,which was to be divided into control group（Separate application of Pulmicort Respules to treat group）40 cases and detection group（Tiotropium bromide combined with Pulmicort Respules to treat group）40 cases.Result：The pulmonary function and quality of life of detection group were better than control group,P0.05,the difference were statistical significance.Conclusion： The clinical symptoms of curing older chronic obstructive pulmonary disease by tiotropium bromide and budesonide was obviously and effect of good.

关 键 词：噻托溴铵 普米克令舒 老年 慢性阻塞性肺疾病 

分 类 号：R563.9[医药卫生—呼吸系统]